Paul C. Barrow has been named director of scientific projects and client consulting at CiToxLAB. With this appointment, CiToxLAB expects to further increase its business in reprotoxicology and juvenile studies. Mr. Barrow and François Spezia, recently recruited from Chanel, Pfizer and HMR, will be working jointly to further develop those capabilities, in conjunction with Scantox, the Danish site of the newly formed group, which has internationally recognized competencies in mini-pig studies. Mr...